Shareholder
RANDY L. SHOEMAKER
Shareholder
Randy has 25 years of experience as an intellectual
property attorney in all aspects of intellectual property
including: patent prosecution; due diligence investigations
property attorney in all aspects of intellectual property
including: patent prosecution; due diligence investigations
RANDY L. SHOEMAKER
Randy has 25 years of experience as an intellectual property attorney in all aspects of intellectual property including: patent prosecution; due diligence investigations; freedom to operate and design around opinions; intellectual property licensing; and trademark matters.
CONTACT ME
EMAIL
ASSISTANT
PHONE
CREDENTIALS
Bar Admissions
State of Michigan
U.S. Patent and Trademark Office
U.S. Patent and Trademark Office
Education
Calvin College (Bachelor of Science in Biology with a Minor in Chemistry, 1983)
Wayne State University School of Medicine (Ph.D. in Pharmacology with a minor in Biochemistry, 1990)
University of Michigan Law School (Juris Doctor, 1996)
Wayne State University School of Medicine (Ph.D. in Pharmacology with a minor in Biochemistry, 1990)
University of Michigan Law School (Juris Doctor, 1996)
Memberships and Associations
State Bar of Michigan
Michigan Intellectual Property Law Association
Licensing Executives Society (LES)
Michigan Intellectual Property Law Association
Licensing Executives Society (LES)
Publications and Presentations
Randall L. Shoemaker and Russell K. Yamazaki, "Peroxisomal Fatty acyl-CoA Oxidase is Not Regulated by Triiodothyronine," Biochim. Biophys. Acta, 1044:169-172, 1990.
Randall L. Shoemaker, "Regulation of Peroxisomal Fatty Acyl-CoA Oxidase and Mitochondrial Glycerol-3-Phosphate Dehydrogenase by Thyroid Hormone and Peroxisomal Proliferators" Ph.D. Thesis, 1990, Wayne State University, Detroit, MI.
Randall L. Shoemaker and Russell K. Yamazaki, "Thyroid Hormone-Independent Regulation of Mitochondrial Glycero-3-Phosphate Dehydrogenase by the Peroxisomal Proliferator Clofibric Acid," Biochemical Pharmacology, 41:652-655, 1991.
Shoemaker, R.L., Bora, G, and Kapatos, G., "Characterization of Acutely Dissociated and Cultured Neonatal Rat Olfactory Bulb Neurons" Society of Neuroscience Abstract, Vol. 17:153, 4, 1991.
Levine, R.A., Anastasiadis, P.Z., Koch, S., Shoemaker, R.L., and Kuhn, D.M., "Studies on the Second Messengers Involved in the Co-Induction of Tetrahydrobiopterin (BH4) and Catecholomine-related Genes in Cultured PC12 Cells," 7th International Conference on Pteridines and Related Biogneic Amines, Pteridines, Vol. 5, No 1, p.35, 1994.
Levine, R.A., Anastasiadis, P.Z., Shoemaker, R.L., States, J.C., and Kuhn, D.M., "Coordinated Regulation of Tetrahydrobiopterin (BH4) and Catecholamine-Related Rat and Human Genes," Society of Neuroscience Abstract, Vol. 20, 1994.
Shoemaker, R.L., Zhang, Z.G., Anastasiadis, P.Z., Imerman, B., Chopp, M., and Levine, R.A., "Nitric Oxide and Tetrahydrobiopterin Metabolism Following Cerebral Ischemia in the Rat," Society of Neuroscience Abstract, Vol. 20, 1994.
Anastasiadis, P.Z., Shoemaker, R.L., Imerman, B., States, J.C., Kuhn, D.M., and Levine, R.A., “The Effect of NGF and EGF on PC12 Cell Proliferation is Mediated by Intracellular Tetrahydrobiopterin”, Soc. Neurosci. Abstr. Vol 20, 1994.
“In re SEAGATE”, Licensing Executives Society, Oct. 16, 2007.
Arizona Engineering Law seminar, “What Every Engineer Should Know About Intellectual Property”, Jan. 22, 2015.
THE LATEST
NEWS
Year End Newsletter 2024
The Year End edition of our newsletter is now available. Here is a brief glance at what you will find in this edition: “Defend Trade Secrets Act,” “When a “skinny label” results in induced...
2 weeks ago
Load More
Fail to load posts. Try to refresh page.
ARTICLES
Blake Schmidt recently published an interesting article in IPLS Proceedings
Blake Schmidt recently published an interesting article in IPLS Proceedings published by the State Bar of Michigan. Blake explained an important rule change proposed by the USPTO that, if implemente...
2 weeks ago
Load More
Fail to load posts. Try to refresh page.
SPEAKING ENGAGEMENTS
Corey M. Beaubien was a guest lecturer
Corey M. Beaubien was a guest lecturer at the Michigan State University College of Law for its Intellectual Property Practice course In March. He discussed subject matter eligibility under 35 U.S.C. �...
2 years ago
Load More
Fail to load posts. Try to refresh page.
Randy L. Shoemaker
Shareholder
Randy has 25 years of experience as an intellectual property attorney in all aspects of intellectual property including: patent prosecution; due diligence investigations; freedom to operate and design around opinions; intellectual property licensing; and trademark matters.
Randy’s experience includes obtaining pharmaceutical and chemical patents for startups and manufacturers, including patents related to: traumatic brain injury; obesity; cancer treatment; anti-inflammation; arthritis; allergic conditions; microbiology and genetics; cell culture systems; diagnostic assay systems; and the creation of and use of nanoparticles in diagnostic analysis and assay systems. He also has expertise in the areas of polymer chemistry, rubbers, elastomers, plastics, nylons and graft polymers, sealants and coatings, lubricants, adhesives, polyvinyl chloride formulations, graphite formulations and uses, ceramics and ceramic coatings, and foams of all sorts.
Randy has prosecuted medical device and methods of use patents in the areas of: surgical instruments; diagnostic devices and assays; insulin pump designs and pump syringes for the same; prosthetic joints and limbs; and near field communication and RFID based devices to monitor a variety of physiological parameters, to provide “lab on a chip” assays, to monitor product storage conditions over time, to provide MEMS to monitor medical devices and structural building parameters, and skin patches to record exposure to a variety of environmental elements.
He has extensive experience in a variety of automotive related technologies and glass formulations. Randy also has a great depth of knowledge related to commercial food manufacturing methods, development of new foods, packaging of food items and the machinery to carry out these processes. Randy’s patent experience also extends to agricultural crop technology and crop treatments including: fertilizer formulations; growth promotor treatments; pest management treatments; and microbial treatments to enhance nutrient utilization and growth.
Randy’s experience includes obtaining pharmaceutical and chemical patents for startups and manufacturers, including patents related to: traumatic brain injury; obesity; cancer treatment; anti-inflammation; arthritis; allergic conditions; microbiology and genetics; cell culture systems; diagnostic assay systems; and the creation of and use of nanoparticles in diagnostic analysis and assay systems. He also has expertise in the areas of polymer chemistry, rubbers, elastomers, plastics, nylons and graft polymers, sealants and coatings, lubricants, adhesives, polyvinyl chloride formulations, graphite formulations and uses, ceramics and ceramic coatings, and foams of all sorts.
Randy has prosecuted medical device and methods of use patents in the areas of: surgical instruments; diagnostic devices and assays; insulin pump designs and pump syringes for the same; prosthetic joints and limbs; and near field communication and RFID based devices to monitor a variety of physiological parameters, to provide “lab on a chip” assays, to monitor product storage conditions over time, to provide MEMS to monitor medical devices and structural building parameters, and skin patches to record exposure to a variety of environmental elements.
He has extensive experience in a variety of automotive related technologies and glass formulations. Randy also has a great depth of knowledge related to commercial food manufacturing methods, development of new foods, packaging of food items and the machinery to carry out these processes. Randy’s patent experience also extends to agricultural crop technology and crop treatments including: fertilizer formulations; growth promotor treatments; pest management treatments; and microbial treatments to enhance nutrient utilization and growth.
